Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ihsan Gursel

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Allergy|April 28, 2020
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?Mayda Gursel, Ihsan Gursel
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Development of CpG ODN Based Vaccine Adjuvant FormulationsMayda Gursel, Ihsan Gursel
Mediators of Inflammation|December 5, 2013
Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDLMayda Gursel, Dennis M Klinman, Ihsan Gursel
Pharmacological Research|January 19, 2016
Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotidesDefne Bayik, Ihsan Gursel, Dennis M Klinman
Molecular Immunology|August 26, 2006
CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysisSven Klaschik, Ihsan Gursel, Dennis M Klinman
Bioresource Technology|February 3, 2009
Biosorption of phenol and 2-chlorophenol by Funalia trogii pelletsGulay Bayramoglu, Ihsan Gursel, Yagmur Tunali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shockHidekazu Shirota, Ihsan Gursel, Mayda Gursel, et al.
Oncoimmunology|January 23, 2015
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanoringsBilgi Gungor, Fuat Cem Yagci, Ihsan Gursel, et al.
Immunological Reviews|July 6, 2004
Use of CpG oligodeoxynucleotides as immune adjuvantsDennis M Klinman, Debra Currie, Ihsan Gursel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
CXCL16 influences the nature and specificity of CpG-induced immune activationMayda Gursel, Ihsan Gursel, Howard S Mostowski, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Allergy|April 28, 2020
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?Mayda Gursel, Ihsan Gursel
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Development of CpG ODN Based Vaccine Adjuvant FormulationsMayda Gursel, Ihsan Gursel
Mediators of Inflammation|December 5, 2013
Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDLMayda Gursel, Dennis M Klinman, Ihsan Gursel
Pharmacological Research|January 19, 2016
Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotidesDefne Bayik, Ihsan Gursel, Dennis M Klinman
Molecular Immunology|August 26, 2006
CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysisSven Klaschik, Ihsan Gursel, Dennis M Klinman
Bioresource Technology|February 3, 2009
Biosorption of phenol and 2-chlorophenol by Funalia trogii pelletsGulay Bayramoglu, Ihsan Gursel, Yagmur Tunali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shockHidekazu Shirota, Ihsan Gursel, Mayda Gursel, et al.
Oncoimmunology|January 23, 2015
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanoringsBilgi Gungor, Fuat Cem Yagci, Ihsan Gursel, et al.
Immunological Reviews|July 6, 2004
Use of CpG oligodeoxynucleotides as immune adjuvantsDennis M Klinman, Debra Currie, Ihsan Gursel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
CXCL16 influences the nature and specificity of CpG-induced immune activationMayda Gursel, Ihsan Gursel, Howard S Mostowski, et al.
Pageof 6